- Home
- DNTH vs INTA Comparison
DNTH vs INTA Comparison
Compare DNTH & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | INTA |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 2.2B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DNTH | INTA |
|---|---|---|
| Price | $83.63 | $22.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $121.00 | $41.43 |
| AVG Volume (30 Days) | 670.0K | ★ 729.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.89 |
| EPS | N/A | ★ N/A |
| Revenue | $2,036,000.00 | ★ $504,120,000.00 |
| Revenue This Year | N/A | $15.91 |
| Revenue Next Year | $29.48 | $13.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.09 |
| 52 Week Low | $16.77 | $19.24 |
| 52 Week High | $96.50 | $58.79 |
Technical Indicators
Market Signals| Indicator | DNTH | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 46.19 |
| Support Level | $33.94 | $20.02 |
| Resistance Level | $88.45 | $24.15 |
| Average True Range (ATR) | 3.83 | 1.27 |
| MACD | -1.66 | 0.12 |
| Stochastic Oscillator | 4.02 | 65.57 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.